The influence of supercritical carbon dioxide (SC-CO2) processing conditions on drug loading and physicochemical properties

International Journal of Pharmaceutics

Volumn 439, Issue 1-2, 2012, Pages 92-99

  Ahern, Robert J ^a   Crean, Abina M ^a   Ryan, Katie B ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Dissolution enhancement; Drug loading; Fenofibrate; Mesoporous silica; Poorly water soluble; SBA 15; Supercritical carbon dioxide

Indexed keywords

CARBON DIOXIDE; FENOFIBRATE; MESOPOROUS SILICA; SILICON DIOXIDE; SUPERCRITICAL CARBON DIOXIDE; UNCLASSIFIED DRUG;

ARTICLE; CARBON DIOXIDE TENSION; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; MOLECULAR WEIGHT; POROSITY; PRIORITY JOURNAL; PROCESSING; SURFACE PROPERTY;

CARBON DIOXIDE; DRUG COMPOUNDING; FENOFIBRATE; POROSITY; SILICON DIOXIDE; SOLUBILITY;

EID: 84867897145     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.09.047     Document Type: Article

References (49)

1. G.L. Amidon, H. Lennernäs, V.P. Shah, and J.R. Crison A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharm. Res. 12 1995 413 420
2. J. Andersson, J. Rosenholm, S. Areva, and M. Linden Influences of material characteristics on ibuprofen drug loading and release profiles from ordered micro- and mesoporous silica matrices Chem. Mater. 16 2004 4160 4167
3. F. Belhadj-Ahmed, E. Badens, P. Llewellyn, R. Denoyel, and G. Charbit Impregnation of vitamin E acetate on silica mesoporous phases using supercritical carbon dioxide J. Supercrit. Fluids 51 2009 278 286
4. S. Brown, G. Rowley, and J.T. Pearson Surface treatment of the hydrophobic drug danazol to improve drug dissolution Int. J. Pharm. 165 1998 227 237
5. J.R. Bush, A. Akgerman, and K.R. Hall Synthesis of controlled release device with supercritical carbon dioxide and cosolvent J. Supercrit. Fluids 41 2007 311 316
6. C. Charnay, S. Begu, C. Tourne-Peteilh, L. Nicole, D.A. Lerner, and J.M. Devoisselle Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property Eur. J. Pharm. Biopharm. 57 2004 533 540
7. Z. Chen, X. Li, H. He, Z. Ren, Y. Liu, J. Wang, Z. LI.; G. Shen, and G. Han Mesoporous silica nanoparticles with manipulated microstructures for drug delivery Colloids Surf. B: Biointerfaces 2012
8. P. Costa, and J.M. Sousa-Lobo Modelling and comparison of dissolution profiles Eur. J. Pharm. Sci. 13 2001 123 133
9. A.C.S.L.S. Coutinho, S.A. Quintella, A.S. Araujo, J.M.F. Barros, A.M.G. Pedrosa, V.J.F. Junior, and M.J.B. Souza Thermogravimetry applied to characterization of SBA-15 nanostructured material J. Therm. Anal. Calorim. 87 2007 457 461
10. C. Crampon, G. Charbit, and E. Neau High-pressure apparatus for phase equilibria studies: solubility of fatty acid esters in supercritical carbon dioxide J. Supercrit. Fluids 16 1999 11 20
11. D.P. Das, K.M. Parida, and B.K. Mishra A study on the structural properties of mesoporous silica spheres Mater. Lett. 61 2007 3942 3945
12. L. Diaz, C.M. Liauwa, M. Edge, N.S. Allena, A. Mcmahon, and N. Rhodes Investigation of factors affecting the adsorption of functional molecules onto gel silicas 1. Flow microcalorimetry and infrared spectroscopy J. Colloid Interface Sci. 287 2005 379 387
13. A. Dokoumetzidis, and P. Macheras A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system Int. J. Pharm. 321 2006 1 11
14. J. Fages, H. Lochard, J.-J. Letourneau, M. Sauceau, and E. Rodier Particle generation for pharmaceutical applications using supercritical fluid technology Powder Technol. 141 2004 219 226
15. A. Galarneau, M. Nader, F. Guenneau, F. Di Renzo, and A. Gedeon Understanding the stability in water of mesoporous SBA-15 and MCM-41 J. Phys. Chem. C 111 2007 8268 8277
16. M.D. Gordillo, M.A. Blanco, A. Molero, and E. Martinez-de-la-Ossa Solubility of the antibiotic penicillin G in supercritical carbon dioxide J. Supercrit. Fluids 15 1999 183 190
17. K. Grodowska, and A. Parczewski Organic solvents in the pharmaceutical industry Acta Pol. Pharm. 67 2010 3 12
18. A. Heinz, K.C. Gordon, C.M. Mcgoverin, T. Rades, and C.J. Strachan Understanding the solid-state forms of fenofibrate - a spectroscopic and computational study Eur. J. Pharm. Biopharm. 71 2009 100 108
19. A. Hillerström, J.V. Stamb, and M. Anderssona Ibuprofen loading into mesostructured silica using liquid carbon dioxide as a solvent Green Chem. 11 2009 662 667
20. P. Horcajada, A. Ramila, J. Perez-Pariente, and M. Vallet-Regi Influence of pore size of MCM-41 matrices on drug delivery rate Microporous Mesoporous Mater. 68 2004 105 109
21. I. Izquierdo-Barba, A. Martinez, A.L. Doadrio, J. Perez-Pariente, and M. Vallet-Regí Release evaluation of drugs from ordered three-dimensional silica structures Eur. J. Pharm. Sci. 26 2005 365 373
22. I. Izquierdo-Barba, M. Colilla, M. Manzano, and M. Vallet-Regí In vitro stability of SBA-15 under physiological conditions Microporous Mesoporous Mater. 132 2010 442 452
23. C.A. Lipinski Drug-like properties and the causes of poor solubility and poor permeability J. Pharmacol. Toxicol. Methods 44 2000 235 249
24. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Delivery Rev. 46 2001 3 26
25. S.J. Macnaughton, and N.R. Foster Solubility of DDT and 2,4-D in supercritical carbon dioxide and supercritical carbon dioxide saturated with water Ind. Eng. Chem. Res. 33 1994 2757 2763
26. S.J. Macnaughton, I. Kikic, N.R. Foster, P. Alessi, A. Cortesi, and I. Columbo Solubility of anti-inflammatory in supercritical carbon dioxide J. Chem. Eng. Data 41 1996 1083 1086
27. I. Madieh, M. Simone, W. Wilson, D. Mehra, and L. Augsburger Investigation of drug-porous adsorbent interactions in drug mixtures with selected porous adsorbents J. Pharm. Sci. 96 2007
28. R. Mellaerts, J.A.G. Jammaer, M. Van Speybroeck, H. Chen, J.V. Humbeeck, P. Augustijns, G. Van den Mooter, and J.A. Martens Physical state of poorly water soluble therapeutic molecules loaded into SBA-15 ordered mesoporous silica carriers: a case study with itraconazole and ibuprofen Langmuir 24 2008 8651 8659
29. R. Mellaerts, K. Houthoofd, K. Elen, H. Chen, M. Van Speybroeck, J. Van Humbeeck, P. Augustijns, J. Mullens, G. Van den Mooter, and J.A. Martens Aging behaviour of pharmaceutical formulations of itraconazole on SBA-15 ordered mesoporous silica carrier material Microporous Mesoporous Mater. 130 2010 154 161
30. E.M. Merisko-Liversidge, and G.G. Liversidge Drug nanoparticles: formulating poorly water-soluble compounds Toxicol. Pathol. 36 2008 43 48
31. Micromeritics, (2006) Gemini VI Operators Manual.
32. H. Miura, M. Kanebako, H. Shirai, H. Nakao, T. Inagi, and K. Terada Enhancement of dissolution rate and oral absorption of a poorly water-soluble drug, K-832, by adsorption onto porous silica using supercritical carbon dioxide Eur. J. Pharm. Biopharm. 76 2010 215 221
33. W.P. Olson Separations in pharmaceutical manufacturing in Separations Technology, Pharmaceutical and Biotechnology Applications 1995 Informa Healthcare
34. S.K. Parida, S. Dash, S. Patel, and B.K. Mishra Adsorption of organic molecules on silica surface Adv. Colloid Interface Sci. 121 2006 77 110
35. I. Pasquali, and R. Bettini Are pharmaceutics really going supercritical? Int. J. Pharm. 364 2008 176 187
36. G.T. Rengarajan, D. Enke, M. Steinhart, and M. Beiner Stabilization of the amorphous state of pharmaceuticals in nanopores J. Mater. Chem. 18 2008 2537 2539
37. G.P. Sanganwar, and R.B. Gupta Dissolution-rate enhancement of fenofibrate by adsorption onto silica using supercritical carbon dioxide Int. J. Pharm. 2008 213 218
38. S.-C. Shen, W.K. Ng, L. Chia, Y.-C. Dong, and R.B.H. Tan Stabilized amorphous state of ibuprofen by co-spray drying with mesoporous SBA-15 to enhance dissolution properties J. Pharm. Sci. 99 2010 1997 2007
39. M. Sliwinska-Bartkowiak, G. Dudziak, R. Gras, R. Sikorski, R. Radhakrishnan, and K.E. Gubbins Freezing behaviour in porous glasses and MCM-41 Colloids Surf. A: Physicochem. Eng. Aspects 187-188 2001 523 529
40. S.-W. Song, K. Hidajut, and S. Kawi Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix-drug interactions Langmuir 21 2005 9568 9575
41. M. Vallet-Regi Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering Chem. - A Eur. J. 12 2006 5934 5943
42. M. Vallet-Regi, F. Balas, and D. Arcos Mesoporous materials for drug delivery Drug Deliv. Syst. 46 2007 7548 7558
43. M. Van-Speybroeck, V. Barillaro, T.D. Thi, R. Mellaerts, J. Martens, J.V. Humbeeck, J. Vermant, P. Annaert, G.V.D. Mooter, and P. Augustijns Ordered mesoporous silica material SBA-15: a broad-spectrum formulation platform for poorly soluble drugs J. Pharm. Sci. 98 2008 2648 2658
44. M. Van-Speybroeck, V. Barillaro, T.D. Thi, R. Mellaerts, J. Martens, J.V. Humbeeck, J. Vermant, P. Annaert, G.V.D. Mooter, and P. Augustijns Ordered mesoporous silica material SBA-15: a broad-spectrum formulation platform for poorly soluble drugs J. Pharm. Sci. 98 2009 2648 2658
45. P. York Strategies for particle design using supercritical carbon dioxide Adv. Drug Deliv. Rev. 60 1999 388 398
46. P. York, U.B. Kompella, and B.Y. Shekunov Supercritical Fluid Technology for Drug Development 2004 Dekker, Marcel Incorporated New York
47. L. Yu Amorphous pharmaceutical solids: preparation, characterization and stabilization Adv. Drug Deliv. Rev. 48 2001 27 42
48. D. Zhao, J. Feng, Q. Huo, N. Melosh, G.H. Fredrickson, B.F. Chmelka, and G.D. Stucky Triblock copolymer synthesis of mesoporous silica with periodic 50 to 300 Angstrom pores Science 279 1998 548 552
49. S. Zheng, L. Gao, and J. Guo Synthesis and characterization of copper(II)-phenanthroline complex grafted organic groups modified MCM-41 Mater. Chem. Phys. 71 2001 174 178